VEGFR Tyrosine Kinase Inhibitor II (Synonyms: Vascular Endothelial Growth Factor Tyrosine Kinase Inhibitor II) |
カタログ番号GC16062 |
VEGFR チロシンキナーゼ阻害剤 II (化合物 3) は、KDR、Flt-1、c-Kit、EGF-R、および c-Src に対してそれぞれ 0.02、0.18、0.24 7.3、および 7 μM の IC50 を持つ強力な血管新生阻害剤です。 .
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 269390-69-4
Sample solution is provided at 25 µL, 10mM.
VEGFR tyrosine kinase inhibitor II is a pyridinyl-anthranilamide compound that inhibits the kinase activities of VEGFR2 (KDR), VEGFR1 (FLT1), and c-Kit (IC50s = 20, 180, and 240 nM, respectively).1 It displays minimal activity against c-Src and EGFR (IC50s = 7 and 7.3 µM, respectively) and is inactive against Cdk1, c-Met, IGF-1R, and PKA (IC50s > 10 µM).1 VEGFR tyrosine kinase inhibitor II has been investigated for its potential to inhibit tumor induced angiogenesis.[1]
Reference:
[1] Furet, P., Bold, G., Hofmann, F., et al. Identification of a new chemical class of potent angiogenesis inhibitors based on conformational considerations and database searching. Bioorganic & Medicinal Chemistry Letters 13(18), 2967-2971 (2003).
Average Rating: 5
(Based on Reviews and 19 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *